Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Ablynx wins E1.8 million grant from IWT
The grant, which is over three years, allows Ablynx to further develop technologies related to its Nanobody platform. Furthermore, this grant will enable Ablynx to expand its intellectual
The grant, which is over three years, allows Ablynx to further develop technologies related to its Nanobody platform. Furthermore, this grant will enable Ablynx to expand its intellectual
Effective immediately, Covance will assume control of the Greenfield campus and 264 Lilly employees will be working for Covance.
Ms Carter will be a key member of Axcess’s executive management team responsible for the financial operations of the company and involved in overall corporate strategic planning. Steve
The Mirasol pathogen reduction technology (PRT) system is a proprietary technology that uses riboflavin and UV light to reduce the levels of infectious pathogens and inactivate white cells
Both Eaton’s Aftertreatment and fuel dosing systems have application for decreasing NOx and particulate matter (PM) emissions from the diesel engines. NOx and PM are an important health
This formulation could potentially be a breakthrough in avoiding the fluid retention or hypersensitivity and extravasation reactions which are associated with Taxotere. Initial preclinical studies have shown a
The contract provides funding of up to $30 million, with additional options that may be triggered at the discretion of the National Institutes of Health (NIH) worth a
The companies will be developing GA101, a humanized anti-CD20 monoclonal antibody engineered to increase both direct- and immune-mediated target cell death, for the potential treatment of hematological malignancies
The partnership between the two companies grants SpineSmith the exclusive rights to sell WAVE’s pre-surgical vibration conditioning technology – effectively introducing the approach to the orthopedic and neurological
Under the terms of the agreements with Solvay, York Pharma has acquired Flammazine and Flammacerium, both brands for the prevention and treatment of infections in burn wounds and